Your search history is turned on.
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - RAMM-Q1-CFO-Jan31-2024 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Jos Roldn, Chief Financial Officer of RAMM Pharma Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of RAMM Pharma Corp. (the issuer) for the ...
Microsoft Word - RAMM-Q1-CEO-Jan31-2024 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Jackie P. Burnett, Chief Executive Officer of RAMM Pharma Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of RAMM Pharma Corp. (the issuer) for...
CSE: RAMM MANAGEMENTS DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED JANUARY 31, 2024 MARCH 28, 2024 RAMM PHARMA CORP. MANAGEMENT DISCUSSION & ANALYSIS FOR THE THREE MONTHS ENDED JANUARY 31, 2024 1 Introduction This Managements Discussion and Analysis (MD&A) has been prepared by management of RAMM Pharma Corp. (RAMM or the Company) with an effective date of March 28, 2024. Throughout this MD&A, unless oth...
RAMM PHARMA CORP. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED JANUARY 31, 2024 AND 2023 (EXPRESSED IN CANADIAN DOLLARS) NOTICE OF NO AUDITOR REVIEW OF THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS Under National Instrument 51-102 Continuous Disclosure Obligations, if an auditor has not performed a review of the interim financial statements, the financial state...
RAMM Pharma Corp. Announces Corporate Update TORONTO, March 28, 2024 -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the Company or "RAMM") (CSE: RAMM), is pleased to advise its shareholders that in accordance with its previously announced strategy of diversifying its product portfolio, in order to reduce its exposure to the strictly regulated environment of Cannabis-based products, it has...
Date: March 19, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
RAMM Pharma Corp. Announces Corporate Update. Toronto, Ontario (March 19, 2024) On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the Company or "RAMM") (CSE: RAMM), announced its intention to complete a non- brokered private placement of up to 20,000,000 units (the Units) of the Company at a price of $0.05 per Unit f...
Date: February 28, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Jos Roldan, Interim Chief Financial Officer of RAMM Pharma Corp., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by referenc...
FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Jackie Burnett, Chief Executive Officer of RAMM Pharma Corp., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in ...
CSE: RAMM MANAGEMENTS DISCUSSION AND ANALYSIS FOR THE YEAR ENDED OCTOBER 31, 2023 FEBRUARY 28, 2024 RAMM PHARMA CORP. MANAGEMENT DISCUSSION & ANALYSIS FOR THE YEAR ENDED OCTOBER 31, 2023 1 Introduction This Managements Discussion and Analysis (MD&A) has been prepared by management of RAMM Pharma Corp. (RAMM or the Company) with an effective date of February 28, 2024. Throughout this MD&A, unless otherwise spe...
Date: February 28, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, ROLDAN, Jos, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable ...